Support for coordinating research on HIV and AIDS
Official title: Administrative Support Core
Funded at Dana-Farber Cancer Inst · NIH-11062371 · Data updated 2026-11-12
This study is all about bringing together different teams and tools to work better on finding solutions for HIV and AIDS, making sure everyone shares information and resources effectively, while also supporting education for those involved in developing an HIV vaccine.
Quick facts
| Grant type | P01 program project |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Dana-Farber Cancer Inst NIH-funded |
| Lab location | 1 site (Boston, United States) |
| Project start | April 1, 2024 |
| Project end | March 31, 2029 |
| Funding year | 2025 |
| Award (this year) | $99,384 |
| NIH project number | 5P01AI181597-02 |
| Project ID | NIH-11062371 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for participation or benefit from this research include individuals affected by HIV or AIDS, as well as those involved in HIV vaccine research.
✕Less likely to help
Patients who are not affected by HIV or AIDS or who are not involved in related research may not receive direct benefits from this research.
What this research studies
This research focuses on enhancing collaboration among various projects and technology components aimed at addressing HIV and AIDS. It involves organizing meetings, managing data sharing, and overseeing the allocation of resources to ensure effective communication and progress reporting. The core will also support educational initiatives related to the research, fostering a collaborative environment for scientists and stakeholders involved in HIV vaccine development.
Why it matters
Potential benefit: If successful, this research could lead to improved strategies for developing vaccines and treatments for HIV and AIDS.
How similar studies have gone: Previous research efforts in coordinating HIV vaccine development have shown promise, indicating that collaborative approaches can lead to significant advancements.
Where this research is happening
-
Dana-Farber Cancer Inst
Boston, United States Active
Researchers
- Principal investigator: Reinherz, Ellis L — Dana-Farber Cancer Inst
- Study coordinator: Reinherz, Ellis L
Related research
Other NIH-funded projects on the same topics.
-
Helping young people with cancer understand their genetic risks
This study is creating a special program to help teenagers and young adults with hereditary cancer risks learn about their health and make smart choices, while also supporting their families along the way.
-
Core administrative hub for a multifaceted cancer center program
A large, international cancer research program at Dana-Farber aims to advance a curative strategy for multiple myeloma by coordinating translational research, clinical trials, and data analysis.
-
Automated, interactive lab tool to define radiation targets in cancer care
Aims to make it easier and safer to outline the area to treat in radiation therapy for cancers by using smart software and a patient-friendly interface.
-
Cancer Atlas Network data hub to share big cancer data
A national project helps researchers store, harmonize, and share large cancer data collections so doctors and scientists can learn from many patients.
-
Bridge-building cancer research partnership for education, outreach, and science
A joint effort between UMass Boston and Harvard Cancer Consortium to accelerate cancer research and education by connecting lower-resourced institutions with a leading cancer center.
-
NexTGen: Next-Generation T cell therapy for childhood cancers
A charity-friendly overview: researchers at Dana-Farber are developing advanced engineered T-cell therapies to treat pediatric solid cancers like brain tumors and sarcomas.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.